Related Experiment Video
Updated: Jun 10, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing's disease
Shrikrishna V Acharya1, Raju A Gopal, Anurag Lila
1Department of Endocrinology, Seth G S Medical College and KEM Hospital, Mumbai 400 012, Maharashtra, India. drshri25@rediffmail.com
Insights
Most children with Cushing's disease (CD) experience delayed skeletal maturation, impacting final height. Early diagnosis is crucial for improving growth outcomes in pediatric patients with CD.
Area of Science:
- Pediatric Endocrinology
- Skeletal Development
Background:
- Pediatric Cushing's disease (CD) often leads to growth retardation.
- Limited data exists on skeletal maturation at diagnosis for pediatric CD.
Purpose of the Study:
- To analyze factors influencing skeletal maturation and final height in Asian Indian pediatric CD patients.
- To investigate the relationship between bone age delay and clinical/biochemical variables.
Main Methods:
- Retrospective analysis of 48 pediatric CD patients (mean age 14.84 years).
- Bone age (BA) determined using the Greulich Pyle method.
- Comparison of BA delay with chronological age (CA), height SDS, and biochemical markers.
Main Results:
- 73% of patients (35/48) exhibited delayed bone age (mean delay 1.6 years).
- BA delay negatively correlated with height SDS (r = -0.594) and positively with CA (r = 0.247).
- No significant correlation found between BA delay and symptom duration, cortisol levels, ACTH, or LDDST results.
Conclusions:
- Delayed bone age is common in pediatric Cushing's disease and correlates with height SDS at diagnosis.
- Early diagnosis of CD may mitigate skeletal maturation delay, potentially improving final height outcomes.
Abstract:
Paediatric Cushing's disease (CD) is usually associated with growth retardation, but there are only few published data on skeletal maturation at diagnosis. We analysed factors contributing to skeletal maturation and final height in Asian Indian patients with paediatric CD. We conducted retrospective analysis of 48 patients (29 males; 19 females) with mean age: 14.84 years at diagnosis (range 9-19 years). A single observer using the Greulich Pyle method determined the bone age (BA) of each child. BA delay, i.e. the difference between chronological age (CA) and BA, was compared with clinical and biochemical variables. BA delay was present in 35/48 (73%) patients (mean delay 1.6 years, range 0.5-5 years) and correlated negatively with height SDS (r = -0.594, P < 0.001) and positively with CA at diagnosis (r = 0.247, P < 0.05). There was no correlation with duration of symptoms before diagnosis, basal cortisol, midnight cortisol, ACTH or percentage suppression of low dose dexamethasone suppression cortisol (LDDST). We could not demonstrate any relationship between the duration of history before diagnosis and height SDS at final height. Mean final height SDS in patients was -1.84. We found that most children with CD had delayed BA and correlated significantly with CA and height SDS at diagnosis. Early diagnosis may reduce delay in skeletal maturation and thus contribute to optimal catch-up growth.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Cushing Syndrome II: Pathophysiology
Nature and Nurture
Pharmacokinetics in Pediatric Patients: Drug Metabolism

